Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesIntravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09
Olasveengen TM et al. – Compared with patients who received ACLS without intravenous drug administration following out–of–hospital cardiac arrest, patients with intravenous access and drug administration had higher rates of short–term survival with no statistically significant improvement in survival to hospital discharge, quality of CPR, or long–term survival.
Related Articles
Out-of-hospital cardiac arrest in patients aged 35 years and under: A 4-year study of frequency and survival in London
Resuscitation, 11/18/09
Relevance Score: 69%
Changes in serum creatinine in the first 24 hours after cardiac arrest indicate prognosis: an observational cohort study
Critical Care, 11/03/09
Relevance Score: 69%
In and Out-of-hospital cardiac arrest and echography: A review
Annales Françaises d'Anesthésie et de Réanimation, 10/22/09
Relevance Score: 69%
Naloxone in cardiac arrest with suspected opioid overdoses
Resuscitation, 11/18/09
Relevance Score: 68%
Body temperature changes are associated with outcomes following in-hospital cardiac arrest and return of spontaneous circulation
Resuscitation, 10/06/09
Relevance Score: 68%
Today in Cardiac/Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population
Pharmacoepidemiology and Drug Safety, 02/09/10
Current Use of Aspirin and Antithrombotic Agents in the United States Among Outpatients With Atherothrombotic Disease
The American Journal of Cardiology, 02/08/10
Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension
Hypertension Research, 02/08/10
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Denosumab Demonstrated Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Prostate Cancer Patients With Bone Metastases
Amgen, 02/09/10
Effectiveness and Safety of Proton Pump Inhibitors in Infantile Gastroesophageal Reflux Disease
Annals of Pharmacotherapy, 02/08/10
Choice of Starting Dose for Molecularly Targeted Agents Evaluated in First-in-Human Phase I Cancer Clinical Trials
Journal of Clinical Oncology, 02/05/10
Article Search
Sponsor
Sponsor